Cross-coupling reactions — the joining of fragments of molecules with the aid of a metal catalyst — are a critical part of pharmaceutical production, usually relying on expensive, rare metals like palladium. Researchers at the University of Rochester and the University of Maryland, partially funded by the U.S. National Science Foundation, developed a three-component cross-coupling...